Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey

ABSTRACT Objectives: To evaluate PSA-age volume (AV) scores in predicting positive prostate biopsy findings in Turkey. Materials and Methods: PSA-AV was calculated by multiplying the patient's age by the prostate volume and dividing it by the PSA level. Sensitivities and specificities of the...

Full description

Bibliographic Details
Published in:	International Brazilian Journal of Urology
Main Authors:	Oktay Uçer, Uğur Yücetaş, İlker Çelen, Gökhan Toktaş, Talha Müezzinoğlu
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2015-10-01
Subjects:	Prostate-Specific Antigen Prostatic Neoplasms Prostate Biopsy Digital Rectal Examination
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000500864&lng=en&tlng=en

Similar Items

The effect on the sensitivities of PSA and PSA-age volume score of IPSS and nocturia in predicting positive prostate biopsy findings
by: O. Üçer, et al.
Published: (2017-06-01)

Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?
by: Jeremy YC Teoh, et al.
Published: (2015-01-01)

Ten-core versus 16-core transrectal ultrasonography guided prostate biopsy for detection of prostatic carcinoma: a prospective comparative study in Indian population
by: V. Surya Prakash, et al.
Published: (2013-12-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Effect of Finasteride on PSA and Histopathological Results in Patients Undergoing Prostate Biopsy
by: Saman Farshid, et al.
Published: (2022-12-01)

Contemporary outcomes in the detection of prostate cancer using transrectal ultrasound-guided 12-core biopsy in Singaporean men with elevated prostate specific antigen and/or abnormal digital rectal examination
by: Alvin Lee, et al.
Published: (2015-10-01)

Role of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy in the Detection of Clinically Significant Prostate Cancer in Patients with Suspicious Digital Rectal Examination
by: Vincenzo Ficarra, et al.
Published: (2024-04-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
by: Mehmet Coşkun, et al.
Published: (2021-02-01)

Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
by: Yiji Peng, et al.
Published: (2025-03-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Accuracy of digital rectal examination to diagnose prostate cancer confirmed by needle biopsy reports: A 3–year hospital-based study
by: Udoh EA, et al.
Published: (2020-12-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1
by: Cheng Wang, et al.
Published: (2021-01-01)

Malakoplakia of the prostate diagnosed by elevated PSA level and transrectal prostate biopsy
by: Sacit Nuri Görgel, et al.
Published: (2011-04-01)

Integration of PSAd and multiparametric MRI to forecast biopsy outcomes in biopsy-naïve patients with PSA 4~20 ng/ml
by: Lei Ren, et al.
Published: (2024-07-01)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
by: Jae Yeon Kim, et al.
Published: (2023-09-01)

Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients
by: Hasan Yilmaz, et al.
Published: (2014-10-01)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
by: Jin-Woo Jung, et al.
Published: (2019-01-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
by: Antonio Benito Porcaro, et al.
Published: (2015-10-01)

Prostate Specific Antigen (PSA): The Historical Perspective
by: T. Ming Chu
Published: (2020-12-01)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml−1
by: Ma-Ping Huang, et al.
Published: (2023-01-01)

PI-RADSv2.1 combined with PSA density for optimizing prostate biopsy decisions: a retrospective analysis
by: Yuchun Li, et al.
Published: (2025-07-01)

Association of Serum PSA, fPSA, and CEA Levels with Prognosis and Clinicopathological Characteristics in Prostate Cancer
by: Ahamed Y, et al.
Published: (2025-08-01)

Association of Connexin 32 with Prostate Volume and PSA Level in Prostatic Adenocarcinoma and Adenomyomatous Hyperplasia
by: Havva Erdem, et al.
Published: (2020-06-01)

DIGITAL RECTAL EXAMINATION, TRANSRECTAL ULTRASOUND AND PROSTATE SPECIFIC ANTIGEN AS A TRIPPLE ASSESMENT DIAGNOSTIC TOOL FOR BENIGN ENLARGEMENT OF PROSTATE
by: Miteshkumar R Trivedi, et al.
Published: (2015-09-01)

Prostate cancer in primary care, Port Harcourt, Nigeria
by: Andrew Bock-Oruma, et al.
Published: (2014-01-01)

Role of Prostate Specific Antigen, Digital Rectal Examination and Trans Rectal Ultrasonography in the Diagnosis of Prostate Cancer in Patients with Lower Urinary Tract Symptoms
by: Sunanda De, et al.
Published: (2014-02-01)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
by: Shuanbao Yu, et al.
Published: (2020-11-01)

Does the type of the previous biopsy affect the fusion prostate biopsy results?
by: Gokhan Sonmez, et al.
Published: (2024-09-01)

Development and validation of risk-stratified biopsy decision pathways incorporating MRI and PSA-derived indicators
by: Pengfei Jin, et al.
Published: (2025-12-01)

Decision regret after prostate biopsy for prostate cancer diagnosis: a Korean multicenter cohort study
by: Hwanik Kim, et al.
Published: (2024-06-01)

Association Between Prostate Cancer Detection Rate and Year of Prostate Biopsy
by: Young Jun Uhm, et al.
Published: (2025-02-01)

Patients’ reactions to digital rectal examination of the prostate
by: Udoh EA, et al.
Published: (2022-05-01)

Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy
by: Jae Ryun Park, et al.
Published: (2024-09-01)

Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
by: Ahmed S. Zakaria, et al.
Published: (2018-08-01)

Development and validation of a prostate cancer risk prediction model for the elevated PSA population
by: Junhui Wu, et al.
Published: (2025-09-01)